Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
1996-03-15
2003-07-22
Ford, John M. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S256000, C514S063000, C514S259500, C514S249000, C544S298000, C544S319000, C544S326000, C544S327000, C544S229000, C544S296000, C544S276000, C544S283000, C544S284000, C544S287000, C544S289000, C544S295000, C544S293000, C544S328000
Reexamination Certificate
active
06596727
ABSTRACT:
The invention relates to novel substituted 4-amino- and 4-alkoxypyrimidines, to processes for their preparation and to their use as pesticides, in particular as insecticides, acaricides and fungicides.
It has already been disclosed that certain substituted 4-aminopyrimidines have a good fungicidal, acaricidal and insecticidal activity (cf. EP-A-57,440, EP-A-196,524, EP-A-264,217, EP-A-276,406, EP-A-323,757, EP-A-326,328, EP-A-326,329, EP-A-326,330, EP-A-356,158, EP-A-370,704, EP-A-411,634, EP-A-424,125, EP-A-452,002, EP-A-459,611, EP-A-447,891). However, the biological activity of these compounds is not satisfactory in all fields of application, in particular when low dosage rates and concentrations are used.
Novel substituted 4-amino- and 4-alkoxypyrimidines of the formula I have been found,
in which
R
1
is hydrogen, halogen, (C
1
-C
4
)-alkyl or (C
3
-C
6
)-cycloalkyl,
R
2
is hydrogen, (C
1
-C
4
)-alkyl, halogen (C
1
-C
4
)-halo-alkyl, (C
1
-C
4
)-alkoxy, (C
1
-C
4
)-haloalkoxy, (C
1
-C
4
)-alkoxy-(C
1
-C
4
)-alkyl, (C
1
-C
4
)-alkylthio, (C
1
-C
4
)-alkylthio-(C
1
-C
4
)-alkyl, (C
1
-C
4
)-alkylamino or di-(C
1
-C
4
)-alkylamino,
R
3
is hydrogen, (C
1
-C
4
)-alkyl, (C
1
-C
4
)-alkoxy, (C
1
-C
4
)-haloalkoxy, halogen, (C
1
-C
4
)-alkylthio, amino, (C
1
-C
4
)-alkylamino or di-(C
1
-C
4
)-alkylamino or
R
2
and R
3
together with the carbon atoms to which they are bonded form an unsaturated 5- or 6-membered isocyclic ring which, if it is a 5-membered ring, can contain an oxygen or sulfur atom in place of CH
2
and which is optionally substituted by 1, 2 or 3 identical or different radicals, these radicals being (C
1
-C
4
)-alkyl, (C
1
-C
4
)-alkoxy, (C
1
-C
4
)-halo-alkyl, preferably trifluoromethyl, (C
1
-C
4
)-halo-alkoxy and/or halogen, or
R
2
and R
3
together with the carbon atoms to which they are bonded form a saturated 5-, 6- or 7-membered isocyclic ring which can contain an oxygen or sulfur atom in place of CH
2
and which is optionally substituted by 1, 2 or 3 (C
1
-C
4
)-alkyl groups,
X is NH or oxygen,
E is a direct bond or a straight-chain or branched (C
1
-C
4
)-alkanediyl group, preferably a direct bond,
Q has the meaning Q
1
and
Q
1
is a cycloalkyl group of the formula II
in which n is an integer from 2 to 7,
R
4
and R
5
are identical or different and are in each case hydrogen, (C
1
-C
12
)-alkyl, (C
3
-C
8
)-cycloalkyl, (C
3
-C
8
)-cyclo alkyl-(C
1
-C
4
)-alkyl, (C
1
-C
8
)-alkoxy, (C
3
-C
8
)-cyclo-alkoxy, (C
1
-C
4
)-alkoxy-(C
1
-C
4
)-alkyl, (C
3
-C
8
)-cyclo-alkyl-(C
1
-C
4
)-alkoxy, tri-(C
1
-C
8
)-alkylsilyl, preferably dimethyl-(C
1
-C
8
)-alkylsilyl or tri-ehtylsilyl, di-(C
1
-C
8
)-alkyl-(C
3
-C
8
)-cycloalkyl-silyl, preferably dimethylcyclohexylsilyl, di-(C
1
-C
8
)-alkyl (phenyl-(C
1
-C
4
)-alkyl)-silyl, preferably dimethyl-(phenyl-(C
1
-C
4
)-alkyl)silyl, di-(C
1
-C
8
)-alkyl-(C
1
-C
4
)-haloalkylsilyl, preferably dimethyl-(C
1
-C
4
)-haloalkylsilyl, dimethylphenyl-silyl, (C
1
-C
4
)-haloalkyl, halogen, (C
1
-C
4
)-haloalkoxy, heteroaryl, phenyl, phenyl-(C
1
-C
4
)-alkyl, benzyloxy, benxzyloxy-(C
1
-C
4
)-alkyl, benzylthio, phenylthio or phenoxy, it being possible for the phenyl rings in the seven last-mentioned radicals to be unsubstituted or provided with one or two substituents and these substituents are identical or different and can be in each case (C
1
-C
8
)-alkyl, (C
3
-C
8
)-cycloalkyl, (C
1
-C
4
)-haloalkyl, preferably trifluoromethyl, halogen, (C
1
-C
4
)-dialkylamino, (C
1
-C
4
)-alkylthio, (C
1
-C
8
)-alkoxy, (C
1
-C
4
)-haloalkoxy, (C
1
-C
4
)-alkoxy-(C
1
-C
4
)-alkoxy, H
5
C
2
-O-[CH
2
-CH
2
-O-]
x
, 2-(tetrahydro-2H-pyran-2-yloxy)-ethoxy, (C
2
-C
8
)-alkenyl, (C
2
-C
8
)-alkynyl, benzyloxy which in the phenyl radical optionally carries one or two identical or different substituents selected from the group comprising (C
1
-C
4
)-alkyl, (C
1
-C
4
)-haloalkyl, (C
1
-C
4
)-alkoxy, (C
1
-C
4
)-haloalkoxy and halogen, or tri-(C
1
-C
4
)-alkylsilylmethoxy, preferably dimethyl-(C
1
-C
4
)-alkylsilylmethoxy, (C
3
-C
8
)-cycloalkyl-(C
1
-C
4
)-alkoxy, 1,3-dioxolan-2-ylmethoxy, tetrahydro-furan-2-ylmethoxy or tetrahydro-2H-pyran-2-ylmethoxy, where, both, R
4
and R
5
do not coincidentally denote hydrogen, and where, in two adjacent substituents which are identical or different and are selected from the group comprising (C
1
-C
8
)-alkyl and (C
1
-C
8
)-alkoxy, in each case one hydrogen atom can be replaced by a joint carbon-carbon bond which links these two substituents, or
R
4
and R
5
together with the cycloalkyl group form a 3-8-membered spirocyclic, preferably saturated spirocyclic, ring system which can contain oxygen or sulfur in place of one or two CH
2
groups or
R
4
and R
5
together with the carbon atoms carrying them form a fused 5- or 6-membered, preferably saturated isocycle, in particular a cyclopentane or cyclohexane system,
X is 2, 3 or 4, preferably 2, or
Q has the meaning Q
2
and
Q
2
is a group of the formula III
in which
R
6
is a group of the formula Z-W and Z is a direct bond or carbonyl or sulfonyl and W is an aryl or heteroaryl group which can be unsubstituted or provided with one or two substituents and these substituents are identical or different and are in each case (C
1
-C
8
)-alkyl, (C
3
-C
8
)-cycloalkyl, trifluoromethyl, halogen (C
1
-C
4
)-alkoxy, (C
1
-C
4
)-dialkylamino or (C
1
-C
4
)-alkylthio.
If Q has the meaning Q
1
, R
2
and R
3
together with the carbon atoms carrying them form an unsaturated 6-membered isocyclic ring and R
4
and R
5
form a fused 5- or 6-membered ring, then the meaning 5-membered ring is preferred for the two last-mentioned radicals.
If Q has meaning Q
1
, and R
2
and R
3
together with the carbon atoms carrying them form a furan or thiophene system, then Q
1
is preferably not (C
3
-C
8
)-cycloalkyl which is optionally substituted and the substituents are in particular alkyl such as (C
1
-C
4
)-alkyl, alkoxy such as (C
1
-C
4
)-alkoxy, haloalkyl such as (C
1
-C
4
)-haloalkyl, haloalkoxy such as (C
1
-C
4
)-haloalkoxy or halogen.
Preferred compounds of the formula I are those in which
R
1
is hydrogen, methyl or cyclopropyl,
R
2
is (C
1
-C
4
)-alkyl, chlorine, methoxy, ethoxy or methoxymethyl,
R
3
is hydrogen, (C
1
-C
3
)-alkyl, methoxy, ethoxy or halogen or
R
2
and R
3
together with the carbon atoms to which they are bonded form an unsaturated 5- or 6-membered ring which can contain an oxygen or sulfur atom, or R
2
and R
3
together with the carbon atoms to which they are bonded form a saturated 5- or 6-membered ring which can contain a sulfur atom,
Q has the meaning Q
1
or Q
2
, in particular those compounds of the formula I in which
R
1
is hydrogen or methyl,
R
2
is methyl, ethyl, methoxy, ethoxy or methoxy-methyl,
R
3
is methyl, ethyl, methoxy, chlorine or bromine, or
R
2
and R
3
together with the carbon atoms to which they are bonded form the quinazoline system, or
R
2
and R
3
together with the carbon atoms to which they are bonded form a saturated 6-membered ring which can contain a sulfur atom and
Q has the meaning Q
1
or Q
2
, preferably those compounds of the formula I in which
E is a direct bond,
R
1
is hydrogen,
R
2
is methyl, ethyl or methoxymethyl,
R
3
is chlorine, bromine or methoxy or
R
2
and R
3
together with the carbon atoms to which they are bonded form the quinazoline system which can be substituted by fluorine, chlorine, bromine or methyl, or
R
2
and R
3
together with the pyrimidine ring form the 5,6,7,8-tetrahydroquinazoline system or the 5,6-dihydro-7H-thiopyrano[2,3-d]pyrimidine or the 5,6-dihydro-8H-thiopyrano[3,4-d]pyrimidine system
and
Q has the meaning Q
1
or Q
2
.
Very particularly preferred compounds of the formula I are those in which
E is a direct bond,
R
1
is hydrogen,
R
2
is methoxymethyl and R
3
is methoxy or
R
2
is methyl or ethyl and R
3
is chlorine or bromine or
R
2
and R
3
together with the carbon atom to which they are bonded form a quinazoline system which is substituted by fluorine, chlorine or methyl, or form a 5,6,7,8-tetrahydroquinazoline system and
Q
Bonin Werner
Braun Peter
Kern Manfred
Knauf Werner
Lümmen Peter
Ford John M.
Frommer & Lawrence & Haug LLP
Hoechst Aktiengesellschaft
Salbeck Gisela
LandOfFree
Substituted pyrimidines, processes for their preparation,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrimidines, processes for their preparation,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrimidines, processes for their preparation,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3088386